MRC1 and breast carcinoma: Our previous epidemiological investigation of MMR gene mutation carriers from Finnish LS families [5] arrived at a standardized incidence ratio of 1.4 for breast cancer compared to the general population, suggesting that breast cancer incidence is not elevated in Finnish LS families.